BioSpace News Archive

Fresh Tracks Therapeutics, Inc. announced financial results for the third quarter ended September 30, 2022 and provided a corporate update.

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended September 30, 2022 after the market closes on Monday, November 21, 2022.

Otonomy, Inc. reported financial results for the quarter ended September 30, 2022 and provided an update on its product pipeline and corporate activities.

VYNE Therapeutics Inc. announced financial results for the three and nine months ended September 30, 2022.

Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. announced a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as Nephron prepares to launch the Company’s InjectEZ component of expansion.

Capricor Therapeutics announced its financial results for the third quarter ended September 30, 2022 and provided a corporate update.

Science 37 Holdings, Inc., the Agile Clinical Trial Operating System™, reported its financial results for the quarter ended September 30, 2022.

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today reported financial results for the third quarter ended September 30, 2022 and provided a corporate update.

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced business updates and financial results for the third quarter ended September 30, 2022.

Sitryx Therapeutics Ltd, a biopharmaceutical company pioneering the field of immunometabolism, announced that the Company will participate in the Stifel 2022 Healthcare Conference, taking place November 15-16, 2022 in New York, NY.